Raymond James Financial
RGEN icon

Raymond James Financial’s Repligen RGEN Stock Holding History

Raymond James Financial’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.4M Sell
168,862
-12
-0% -$1.68K 0.01% 1494
2025
Q4 		$27.9M Buy
168,874
+18,732
+12% +$2.93M 0.01% 1214
2025
Q3 		$20.1M Sell
150,142
-205,902
-58% -$25M 0.01% 1410
2025
Q2 		$44.3M Sell
356,044
-4,716
-1% -$600K 0.02% 831
2025
Q1 		$45.9M Sell
360,760
-3,921
-1% -$604K 0.02% 764
2024
Q4 		$52.5M Buy
+364,681
New +$52.3M 0.02% 699

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Raymond James Financial's RGEN Position: Q1 2026 in Review

Raymond James Financial reduced its Repligen (RGEN) stake by 0.01% in Q1 2026, selling an estimated $1.68K and leaving 168,862 shares worth $19.4M. The position accounts for 0.01% of the portfolio, ranked #1494.

Raymond James Financial first reported a position in RGEN in Q4 2024 and has held it in 6 quarters since. The position peaked at $52.5M in Q4 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Raymond James Financial held 168,862 shares of Repligen worth $19.4M as of Q1 2026.
  • Raymond James Financial sold 12 Repligen shares in Q1 2026, an estimated $1.68K.
  • Repligen made up 0.01% of Raymond James Financial's portfolio in Q1 2026, its #1494 holding.
  • Raymond James Financial first reported a position in Repligen in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Repligen position peaked at $52.5M in Q4 2024.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.